| BLUJEPA Glaxo Group Limited
98126258 10 Aug 2023 | on 22 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "BLUJEPA" to the left of a stylized bow and arrow. | | | Logo Mark Glaxo Group Limited
98126260 10 Aug 2023 | on 22 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized bow and arrow. | | | KEPZAVYQ Glaxo Group Limited
97541157 09 Aug 2022 | on 15 Oct 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | LEXIVA VIIV HEALTHCARE COMPANY
78312751 13 Oct 2003 | on 29 Aug 2024
| Antiviral pharmaceutical preparations and substances Class 005 Class 005 Pharmaceutical Products Antiviral pharmaceutical preparations and substances | | | ZABTESI Glaxo Group Limited
98095382 21 Jul 2023 | on 30 Jul 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | BYNTRUS Glaxo Group Limited
97081801 19 Oct 2021 | on 30 Jul 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | ITRUSVYQUE Glaxo Group Limited
97541162 09 Aug 2022 | on 09 Jul 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | RESMAXVY Glaxo Group Limited
97542578 10 Aug 2022 | on 09 Jul 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | NATVYMUNE Glaxo Group Limited
97542606 10 Aug 2022 | on 09 Jul 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | REXNESSVY Glaxo Group Limited
97542610 10 Aug 2022 | on 09 Jul 2024
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | 
